Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading up more than4 percent on Monday afternoon, thanks to Citron Research's Andrew Left.
The activist investor told Real Money that he's long the pharmaceutical he so passionately ousted and dissed until very recently. However, the famed short-seller disclosed and confirmed to Benzinga the ownership of some out-of-the-money puts, usually used as short investment vehicles.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Related Link: Valeant Reveals Expanded Discounts For Its Nitropress And Isuprel
Left "wouldn't be surprised if there's a bounce" in Valeant’s stock, following its decline of roughly 90 percent over the past year. The investor noted he's "unfazed" by the company’s decision to increase discounts on two its Nitropress and Isuprel drugs.
To be fair, Left's position came after Valeant changed its CEO. The former Chief Executive, Michael Pearson, was openly shareholder-focused rather than patient-focused – and this was one of Left's main problems with the company.
The new CEO, Joseph Papa, on the other hand, has repeatedly talked about his commitment to patients, and backed his words with actions – mostly product discounts.
Shares traded recently at $27.13, up 4.6 percent on the day.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.